ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast for Editas Medicine Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Editas Medicine EDIT at this time. Stock is falling and might fall more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

Although my analysis for Editas Medicine is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 2.4, for a target of 2.7 or 2.88

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

Kalpataru, Shangrila Infracon plan debt fundraise via private credit funds: Report They are likely to receive interest from private credit funds, which have ?been on the lookout for decent-sized deals, one of the sources said. - NEWS as on 2026-05-20 indiatimes.com

Gold loans are no longer merely the last source of credit for the poor: Shaji Varghese, CEO, Muthoot FinCorp Muthoot Fincorp is gearing up for a monumental ?4,000 crore IPO, seeking to ignite its expansion plans and harness the momentum of its current growth trajectory. With an optimistic eye on the future, the company is poised to navigate market fluctuations an - NEWS as on 2026-05-18 indiatimes.com

Lighthouse Canton launches Rs 1,200 cr private credit fund to tap India’s evolving lending landscape Lighthouse Canton has launched its third India-focused private credit fund, targeting Rs 1,200 crore to capitalise on the country’s expanding private credit market. The fund will focus on structured credit investments in mid-to-large corporates, aiming to - NEWS as on 2026-05-15 indiatimes.com

Goldman Sachs' private credit fund cuts value by 3.7% Goldman Sachs BDC reported net asset value ?per share (NAV) of .17 at the end of March, which is roughly 3.7% lower than the ?previous quarter, it said in a late Thursday filing. - NEWS as on 2026-05-08 indiatimes.com

ECLGS 5.0 to help SBI open ?70,000–?80,000 crore credit line: Chairman CS Setty In a pivotal stride towards economic recovery, the government has unveiled ECLGS 5.0, aimed at fortifying MSMEs and the airline industry amidst ongoing challenges. With an unprecedented allocation of Rs 2.55 lakh crore in extra credit, State Bank of India - NEWS as on 2026-05-07 indiatimes.com

Capital One’s Big Bet Faces Rising Credit Risk It’s complicated, but just you wait. That’s the message from Capital One (NYSE: COF) in light of its first-quarter results as it undertakes a significant rejiggering of its business. For many investors, that’s not been a convincing argume - NEWS as on 2026-05-06 nasdaq.com

Cabinet clears Emergency Credit Line Guarantee Scheme 5.0 to cushion MSMEs, airlines amid Gulf war The government has approved a new credit scheme, ECLGS 5.0, to support airlines and small businesses facing economic challenges. This initiative will provide significant additional credit. Two new semiconductor manufacturing units are also set to be establ - NEWS as on 2026-05-06 indiatimes.com

Banks record robust 15.9% credit growth in FY26: Finance Ministry Indian banks saw strong credit growth of 15.9 percent in the 2025-26 fiscal year. This reflects a vibrant economy and high demand for loans. Services, personal loans, agriculture, and industry all contributed to this expansion. The Finance Ministry highlig - NEWS as on 2026-05-05 indiatimes.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 2.67
  • 12Day Average: 2.91
  • 20Day Average: 2.94
  • 50Day Average: 2.82
  • 100Day Average: 2.41
  • 150Day Average: 2.54
  • 200Day Average: 2.65

EDIT Indicators & signals

Indicator MACD (12,26,9)

2.82, 2.88, 0.02
Indicator MACD is in negative zone

Indicator ADX (14)

6.67, 31.82, 36.36
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Tue May 2026 2.47 2.42 to 2.57 -2.37% 0.7 times
18 Mon May 2026 2.53 2.47 to 2.69 -3.44% 1.08 times
15 Fri May 2026 2.62 2.57 to 2.88 -8.07% 1.1 times
14 Thu May 2026 2.85 2.73 to 2.94 -1.72% 0.98 times
13 Wed May 2026 2.90 2.86 to 2.95 -1.02% 0.8 times
12 Tue May 2026 2.93 2.90 to 3.08 -4.25% 0.88 times
11 Mon May 2026 3.06 3.03 to 3.27 -1.61% 0.94 times
08 Fri May 2026 3.11 3.03 to 3.23 2.64% 0.96 times
07 Thu May 2026 3.03 2.97 to 3.25 -4.72% 1.24 times
06 Wed May 2026 3.18 3.05 to 3.18 0% 0.94 times
06 Wed May 2026 3.18 3.05 to 3.18 4.61% 1.07 times
05 Tue May 2026 3.04 2.92 to 3.16 1.33% 1.09 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top